Form4insider filings, from the source

SEC Form 3 · accession 0001209191-18-048682

Cidara Therapeutics, Inc. · CDTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Brady Johnson
Officer — Dir. of Finance & Controller
Period of report
Aug 17, 2018
Accepted (ET)
Aug 28, 2018 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———3,721D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F1$6.86holding————Feb 24, 2025Common Stock6,248—D
Stock Option (right to buy)F2$9.89holding————Mar 15, 2026Common Stock1,875—D
Stock Option (right to buy)F3$7.80holding————Mar 30, 2027Common Stock6,000—D
Stock Option (right to buy)F4$4.00holding————Mar 28, 2028Common Stock5,000—D

Explanation of responses